Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks

doi:10.12998/wjcc.v9.i18.4690

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3347)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-8) series.

Item

Count

PDF

230

WORD

HTML

1916

Tables (1-8)

143

Sum=2387

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

325

Download

635

Sum=960

Jun 26, 2021 (publication date) through May 7, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Clin Cases. Jun 26, 2021; 9(18): 4690-4699
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4690

Table 4 Proportions of participants with undetectable levels of hepatitis B virus DNA (< 20 IU/mL) in the two groups

	HBeAg-positive CHB			HBeAg-negative CHB
Group	n	72 wk	96 wk	n	72 wk	96 wk
A	114	74 (64.91)	81 (71.05)	47	40 (85.11)	41 (87.23)
B	118	81 (68.64)	92 (77.97)	51	48 (94.12)	48 (94.12)
P value		0.5788	0.2326		0.1877	0.3046

Values are presented as n (%). HBeAg: Hepatitis B e antigen; CHB: Chronic hepatitis B.

Citation: Chen XF, Fan YN, Si CW, Yu YY, Shang J, Yu ZJ, Mao Q, Xie Q, Zhao W, Li J, Gao ZL, Wu SM, Tang H, Cheng J, Chen XY, Zhang WH, Wang H, Xu ZN, Wang L, Dai J, Xu JH. Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks. World J Clin Cases 2021; 9(18): 4690-4699
URL: https://www.wjgnet.com/2307-8960/full/v9/i18/4690.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i18.4690